Skip to main content
Figure 1 | Genetic Vaccines and Therapy

Figure 1

From: The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model

Figure 1

Overexpression of EGFR in LL2 lung cancer cell line. The expression of EGFR in various cell lines was analyzed by Western blotting with monoclonal antibody against EGFR. (B) Flow cytometry analysis of membrane EGFR in LL2 cells. LL2 cells were stained with monoclonal antibody against the extracellular domain of mouse EGFR, followed by FITC-conjugated mouse anti-goat secondary antibody (gray histogram). Normal mouse IgG mAb was used as the negative control (white histogram).

Back to article page

Genetic Vaccines and Therapy

ISSN: 1479-0556